Medtronic received FDA clearance for its Hugo robotic-assisted surgery system for urologic procedures.
The clearance allows the system to be used in minimally invasive surgeries, including prostatectomy, nephrectomy and cystectomy — procedures that account for approximately 230,000 cases annually in the U.S., according to a Dec. 3 company news release.
Rajit Kamal, vice president and general manager of robotic surgical technologies at Medtronic, said in the release that the company is beginning a targeted U.S. launch with select hospitals. The system has been used in tens of thousands of surgeries across more than 30 countries on five continents.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
